Related Experiment Videos

Norgestrel, increased lipids: fact or "marketing monster"?

    Contraceptive Technology Update
    |October 1, 1989
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    AmericasArterial Occlusive DiseasesArteriosclerosisAtherosclerosisBiologyContraceptionContraceptive AgentsContraceptive Agents, EstrogenContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive MethodsDeveloped CountriesDiseasesEthinyl EstradiolFamily PlanningLevonorgestrelLipid Metabolic EffectsLipidsNorethindroneNorgestrelNorth AmericaNorthern AmericaOral ContraceptivesOral Contraceptives, CombinedOral Contraceptives, PhasicPhysiologyUnited StatesVascular Diseases

    Related Concept Videos